Wearable Health Sensors and Diagnosis

Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

Wearable Health Sensors and Diagnosis

Sector: Diagnostics
Topic: Bio Break
YouTube video thumbnail

Wearable health sensors are becoming more capable as smartwatches and other devices continue to evolve. In this Bio Break episode, Nick and Nigel explore how a surprisingly small set of sensors could be used to identify a wide range of common health conditions. The conversation starts casually with a comparison between a simple Timex watch and modern smartwatches, but it quickly moves into deeper questions about sensing, diagnosis, and where wearables fit between wellness and medical devices.

How Wearable Health Sensors Are Expanding

As wearables become more advanced, they can sense more signals from the body. Nigel shares a long-standing interest in whether a limited number of sensors could diagnose many conditions. Rather than adding endless hardware, the idea focuses on selecting sensors that overlap across multiple use cases. This approach keeps systems simpler while still delivering meaningful insights.

Importantly, the discussion highlights the tension companies like Apple have faced when deciding whether a product is a wellness device or a regulated medical device. That distinction shapes how wearable health sensors are designed, validated, and positioned in the market.

Diagnosing Common Conditions with Fewer Sensors

Using a paper-based analysis, Nigel estimates that around 46 common conditions could be identified using just five sensors. These conditions tend to be ones with external or observable symptoms and may be chronic or episodic. Examples mentioned in the episode include pregnancy, common colds, asthma, and breathing difficulties.

Rather than chasing rare diagnoses, this model prioritizes conditions people experience frequently. As a result, wearable sensors can deliver more value without unnecessary complexity.

Finding the Core Sensor Set

Not every condition makes sense to include. Adding a sensor to capture only one or two extra diagnoses quickly becomes inefficient. Instead, the conversation points to a core group of sensors that form a nucleus. This nucleus provides the greatest overlap across many conditions, which is key for scalable wearable health sensors.

Reliability Still Matters

Despite all the potential of smart devices, the episode closes with a reminder that reliability is still valued. A simple watch may not diagnose conditions, but it works consistently. That contrast underscores the challenge for wearable diagnostics as they move closer to medical use.

Sterile assurance level concept showing gloved hands opening a sterile medical device pouch with “Truly sterile?” text overlay

Nick and Nigel walk through how sterile disposables are processed and verified before they reach the field.

FDA agentic AI reviewer concept with robotic hand reviewing medical device submission documents

The FDA agentic AI is making headlines after the agency announced its own internal AI review tool. In this episode of MedDevice by Design, Ariana and Mark discuss what this could mean for medical device submissions and regulatory efficiency.

Thumbnail showing a cartoon sandwich icon with the text “Sandwich ELISA?” and a red arrow pointing to the sandwich.

The sandwich ELISA assay is one of the most common ELISA formats used in diagnostics. Nick and Nigel walk through the method step by step using simple visuals and plain language.

Engineers conducting pre-clinical testing of a novel medical device in a controlled laboratory environment

For manufacturers of novel devices that can make a significant impact to patient health, the goal of the program is to offer a path to streamlined and potentially faster market entry without sacrificing the rigour around ensuring safety and performance.